Dr. Fei Chen is a clinician-scientist and academic pathologist with a sustained research focus on molecular pathology, cytopathology, and translational diagnostics. Their scholarly work spans cancer genomics, liquid biopsy, molecular testing of cytology specimens, and the integration of advanced technologies such as next-generation sequencing and artificial intelligence into diagnostic pathology. With 16 peer-reviewed documents, their publications appear in high-impact journals across pathology, oncology, and molecular medicine, reflecting contributions to bladder, prostate, thyroid, lung, and neurodegenerative disease research. This body of work has accrued approximately 75 citations, underscoring its relevance and influence within the research community. An h-index of 5 highlights consistent scholarly impact across multiple publications. In addition to original research and systematic reviews, their work includes multi-institutional studies and method-validation research that bridges laboratory innovation with clinical application, contributing to evidence-based advancements in modern diagnostic and molecular pathology.